HNI (HNI) Financials

$46.51 -0.32 (-0.68%)

Closing price 03:59 PM Eastern

Extended Trading

$46.50 -0.01 (-0.02%)

As of 04:21 PM Eastern

Annual Income Statements for HNI

This table shows HNI's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/28/2024	12/30/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	140	49	124
Consolidated Net Income / (Loss)	140	49	124
Net Income / (Loss) Continuing Operations	140	49	124
Total Pre-Tax Income	179	65	146
Total Operating Income	207	90	155
Total Gross Profit	1,033	948	835
Total Revenue	2,526	2,434	2,362
Operating Revenue	2,526	2,434	2,362
Total Cost of Revenue	1,493	1,486	1,527
Operating Cost of Revenue	1,493	1,486	1,527
Total Operating Expenses	827	858	680
Selling, General & Admin Expense	821	813	723
Restructuring Charge	6.20	45	6.70
Other Special Charges / (Income)	0.00	0.00	-50
Total Other Income / (Expense), net	-27	-26	-8.80
Interest & Investment Income	-27	-26	-8.80
Income Tax Expense	40	16	23
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.00	0.00
Basic Earnings per Share	$2.95	$1.11	$2.97
Weighted Average Basic Shares Outstanding	47.40M	44.50M	41.70M
Diluted Earnings per Share	$2.88	$1.09	$2.94
Weighted Average Diluted Shares Outstanding	48.50M	45.40M	42.20M
Weighted Average Basic & Diluted Shares Outstanding	47.02M	46.89M	41.41M
Cash Dividends to Common per Share	$1.31	$1.28	$1.27

This table shows HNI's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Income / (Loss) Attributable to Common Shareholders	14	38	48	36	18	23	38	-13	1.60	16	63
Consolidated Net Income / (Loss)	14	38	48	36	18	23	38	-13	1.60	16	63
Net Income / (Loss) Continuing Operations	14	38	48	36	18	23	38	-13	1.50	16	63
Total Pre-Tax Income	19	50	62	46	22	23	47	-9.00	3.80	21	80
Total Operating Income	24	55	69	53	30	31	57	-3.60	6.40	23	82
Total Gross Profit	238	261	279	261	233	273	285	216	174	208	210
Total Revenue	600	643	672	624	588	680	712	564	479	569	599
Operating Revenue	600	643	672	624	588	680	712	564	479	569	599
Total Cost of Revenue	361	382	393	362	355	407	426	348	305	361	389
Operating Cost of Revenue	361	382	393	362	355	407	426	348	305	361	389
Total Operating Expenses	214	206	210	208	203	242	229	219	168	185	128
Selling, General & Admin Expense	208	203	208	206	203	211	223	211	168	179	178
Restructuring Charge	6.40	2.50	1.60	2.00	0.10	31	5.30	8.10	0.00	-	0.00
Total Other Income / (Expense), net	-5.50	-5.10	-7.10	-7.40	-7.60	-7.90	-9.40	-5.50	-2.70	-2.30	-2.50
Interest & Investment Income	-5.50	-5.10	-7.10	-7.40	-7.60	-7.90	-9.40	-5.50	-2.70	-2.30	-2.40
Income Tax Expense	5.00	11	14	10	4.30	-	9.60	3.80	2.20	4.30	16
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	-	0.00	0.00	0.00	-	0.00	0.00	0.00	-	0.00
Basic Earnings per Share	$0.30	$0.81	$1.00	$0.76	$0.38	$0.56	$0.81	($0.30)	$0.04	$0.38	$1.53
Weighted Average Basic Shares Outstanding	47M	47.40M	47.70M	47.20M	47.10M	44.50M	46.60M	43.30M	41.50M	41.70M	41.30M
Diluted Earnings per Share	$0.29	$0.78	$0.98	$0.75	$0.37	$0.55	$0.80	($0.30)	$0.04	$0.38	$1.51
Weighted Average Diluted Shares Outstanding	48M	48.50M	48.70M	48.20M	48.10M	45.40M	47.30M	43.30M	42.10M	42.20M	41.80M
Weighted Average Basic & Diluted Shares Outstanding	46.55M	47.02M	47.80M	47.14M	47.30M	46.89M	46.58M	46.55M	41.70M	41.41M	41.36M
Cash Dividends to Common per Share	$0.33	-	$0.33	$0.33	$0.32	-	$0.32	$0.32	$0.32	-	$0.32

This table details how cash moves in and out of HNI's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/28/2024	12/30/2023	12/31/2022
Net Change in Cash & Equivalents	-6.40	12	-35
Net Cash From Operating Activities	227	268	81
Net Cash From Continuing Operating Activities	227	268	81
Net Income / (Loss) Continuing Operations	140	49	124
Consolidated Net Income / (Loss)	140	49	124
Depreciation Expense	108	95	84
Non-Cash Adjustments To Reconcile Net Income	13	54	-31
Changes in Operating Assets and Liabilities, net	-33	69	-96
Net Cash From Investing Activities	-51	-445	-11
Net Cash From Continuing Investing Activities	-51	-445	-11
Purchase of Property, Plant & Equipment	-51	-78	-60
Acquisitions	-2.30	-371	-20
Purchase of Investments	-3.20	-5.70	-2.80
Divestitures	0.00	2.70	70
Sale and/or Maturity of Investments	4.70	5.40	2.30
Other Investing Activities, net	0.40	1.60	0.00
Net Cash From Financing Activities	-182	189	-105
Net Cash From Continuing Financing Activities	-182	189	-105
Repayment of Debt	-421	-439	-406
Repurchase of Common Equity	-66	-0.30	-65
Payment of Dividends	-64	-59	-53
Issuance of Debt	317	684	414
Issuance of Common Equity	51	2.30	4.70

This table details how cash moves in and out of HNI's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Net Change in Cash & Equivalents	-1.40	-12	6.00	1.30	-2.00	4.60	0.60	6.80	-0.50	-3.60	1.50
Net Cash From Operating Activities	13	51	129	51	-4.30	105	123	23	17	47	59
Net Cash From Continuing Operating Activities	13	51	128	51	-4.20	105	123	22	17	47	59
Net Income / (Loss) Continuing Operations	14	38	48	36	18	23	38	-13	1.60	16	63
Consolidated Net Income / (Loss)	14	38	48	36	18	23	38	-13	1.60	16	63
Depreciation Expense	26	28	27	26	26	27	26	23	20	21	21
Non-Cash Adjustments To Reconcile Net Income	13	-6.10	4.20	5.90	8.60	37	6.90	5.00	5.40	12	-53
Changes in Operating Assets and Liabilities, net	-40	-8.60	49	-17	-57	19	52	7.70	-9.70	-2.10	28
Net Cash From Investing Activities	-12	-9.30	-15	-16	-11	-17	-17	-391	-20	-24	56
Net Cash From Continuing Investing Activities	-12	-9.40	-15	-17	-11	-17	-17	-391	-20	-24	56
Purchase of Property, Plant & Equipment	-16	-9.40	-14	-17	-11	-16	-24	-	-	-18	-14
Acquisitions	-0.60	-0.30	-0.60	-0.90	-0.50	-0.10	2.60	-373	-0.20	-3.60	-1.60
Purchase of Investments	-0.10	-0.10	-1.20	-1.30	-0.60	-1.90	-0.70	-1.50	-1.60	-0.50	-0.50
Sale of Property, Plant & Equipment	3.50	-	-	-	-	-	-	-	-	-	-
Sale and/or Maturity of Investments	0.70	0.20	1.10	2.20	1.20	1.40	1.00	1.50	1.50	0.40	0.40
Net Cash From Financing Activities	-1.10	-54	-108	-34	13	-83	-105	375	2.10	-27	-120
Net Cash From Continuing Financing Activities	-1.10	-54	-108	-34	13	-84	-105	375	2.20	-27	-120
Repayment of Debt	-68	-57	-161	-115	-87	-127	-144	-86	-82	-107	-137
Repurchase of Common Equity	-40	-41	-11	-11	-2.60	-0.30	-	-	0.00	-	-
Payment of Dividends	-16	-16	-16	-16	-17	-15	-15	-15	-14	-13	-13
Issuance of Debt	123	54	37	107	119	59	53	475	97	92	30
Issuance of Common Equity	0.80	5.80	44	0.60	0.60	0.50	0.60	0.60	0.60	0.70	0.60
Other Net Changes in Cash	-0.60	-	-	-	-	-	-	-	-	-	-

This table presents HNI's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/28/2024	12/30/2023	12/31/2022
Total Assets	1,875	1,929	1,415
Total Current Assets	525	536	469
Cash & Equivalents	23	29	17
Short-Term Investments	6.40	5.60	2.00
Accounts Receivable	-2.00	-3.50	215
Inventories, net	194	197	180
Prepaid Expenses	55	61	54
Other Current Assets	248	247	-
Plant, Property, & Equipment, net	530	555	353
Plant, Property & Equipment, gross	1,178	1,194	943
Accumulated Depreciation	649	639	590
Total Noncurrent Assets	821	838	593
Noncurrent Note & Lease Receivables	14	12	11
Goodwill	624	652	440
Other Noncurrent Operating Assets	183	174	142
Total Liabilities & Shareholders' Equity	1,875	1,929	1,415
Total Liabilities	1,035	1,167	798
Total Current Liabilities	478	464	395
Short-Term Debt	50	7.50	1.30
Accounts Payable	391	419	368
Other Current Liabilities	36	38	26
Total Noncurrent Liabilities	557	703	403
Long-Term Debt	294	428	189
Capital Lease Obligations	8.90	7.90	7.70
Noncurrent Deferred & Payable Income Tax Liabilities	72	85	61
Other Noncurrent Operating Liabilities	183	182	145
Total Equity & Noncontrolling Interests	840	762	617
Total Preferred & Common Equity	840	761	617
Preferred Stock	0.00	0.00	0.00
Total Common Equity	840	762	617
Common Stock	249	249	91
Retained Earnings	600	524	534
Accumulated Other Comprehensive Income / (Loss)	-8.30	-11	-8.00
Noncontrolling Interest	0.30	0.30	0.30

This table presents HNI's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/29/2025	9/28/2024	6/29/2024	3/30/2024	9/30/2023	7/1/2023	4/1/2023	10/1/2022
Total Assets	1,858	1,913	1,941	1,913	2,017	2,076	1,383	1,499
Total Current Assets	529	562	568	527	572	598	447	540
Cash & Equivalents	21	34	28	27	24	24	17	21
Short-Term Investments	6.40	5.90	5.30	5.50	5.80	5.70	2.00	2.00
Accounts Receivable	235	259	257	229	259	256	188	-2.40
Inventories, net	205	210	223	212	229	235	191	222
Prepaid Expenses	49	52	55	54	55	59	50	53
Other Current Nonoperating Assets	14	-	-	-	-	19	-	-
Plant, Property, & Equipment, net	519	540	548	552	560	580	355	349
Plant, Property & Equipment, gross	1,158	1,196	1,204	1,205	1,184	1,193	956	945
Accumulated Depreciation	639	657	656	653	624	613	601	595
Total Noncurrent Assets	810	812	825	833	885	898	581	610
Noncurrent Note & Lease Receivables	14	12	13	12	12	12	11	11
Goodwill	618	632	639	646	693	702	433	452
Other Noncurrent Operating Assets	178	169	173	176	179	185	137	147
Total Liabilities & Shareholders' Equity	1,858	1,913	1,941	1,913	2,017	2,076	1,383	1,499
Total Liabilities	1,054	1,066	1,153	1,141	1,276	1,360	770	892
Total Current Liabilities	444	514	474	408	502	489	353	460
Short-Term Debt	50	51	51	13	15	1.10	1.60	1.20
Accounts Payable	349	431	391	364	451	439	326	435
Other Current Liabilities	37	32	33	31	36	35	25	24
Other Current Nonoperating Liabilities	7.60	-	-	-	-	14	-	-
Total Noncurrent Liabilities	1,415	1,399	1,467	1,505	1,515	1,586	1,030	432
Long-Term Debt	355	295	412	460	493	597	206	200
Noncurrent Deferred & Payable Income Tax Liabilities	70	73	78	83	82	73	60	65
Other Noncurrent Operating Liabilities	990	1,031	977	962	939	916	764	160
Total Equity & Noncontrolling Interests	0.30	0.30	0.30	0.30	0.30	0.30	0.30	606
Total Preferred & Common Equity	804	847	788	772	741	715	613	606
Total Common Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Noncontrolling Interest	0.30	0.30	0.30	0.30	0.30	0.30	0.30	0.30

This table displays calculated financial ratios and metrics derived from HNI's official financial filings.

Metric	2024	2023	2022
Period end date	12/28/2024	12/30/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	3.80%	3.06%	8.12%
EBITDA Growth	69.71%	-22.64%	42.08%
EBIT Growth	128.68%	-41.82%	81.73%
NOPAT Growth	134.33%	-47.80%	101.38%
Net Income Growth	183.54%	-60.29%	107.19%
EPS Growth	164.22%	-62.93%	116.18%
Operating Cash Flow Growth	-15.25%	229.43%	-38.30%
Free Cash Flow Firm Growth	154.21%	43.01%	-190.84%
Invested Capital Growth	-0.51%	47.30%	540.10%
Revenue Q/Q Growth	-1.45%	4.77%	-1.42%
EBITDA Q/Q Growth	8.60%	7.93%	4.68%
EBIT Q/Q Growth	13.03%	9.32%	7.70%
NOPAT Q/Q Growth	8.25%	21.51%	7.11%
Net Income Q/Q Growth	12.68%	14.69%	7.01%
EPS Q/Q Growth	8.68%	18.48%	6.52%
Operating Cash Flow Q/Q Growth	-19.18%	27.50%	5.45%
Free Cash Flow Firm Q/Q Growth	-48.15%	-183.06%	-3,147.37%
Invested Capital Q/Q Growth	281.47%	144.77%	0.37%
Profitability Metrics	-	-	-
Gross Margin	40.90%	38.96%	35.35%
EBITDA Margin	12.44%	7.61%	10.14%
Operating Margin	8.17%	3.71%	6.57%
EBIT Margin	8.17%	3.71%	6.57%
Profit (Net Income) Margin	5.52%	2.02%	5.25%
Tax Burden Percent	77.80%	75.93%	84.63%
Interest Burden Percent	86.83%	71.76%	94.33%
Effective Tax Rate	22.20%	24.07%	15.37%
Return on Invested Capital (ROIC)	13.76%	6.97%	28.58%
ROIC Less NNEP Spread (ROIC-NNEP)	7.99%	0.38%	33.76%
Return on Net Nonoperating Assets (RNNOA)	3.66%	0.16%	-8.04%
Return on Equity (ROE)	17.41%	7.14%	20.54%
Cash Return on Invested Capital (CROIC)	14.27%	-31.28%	-117.37%
Operating Return on Assets (OROA)	10.86%	5.40%	10.66%
Return on Assets (ROA)	7.33%	2.94%	8.51%
Return on Common Equity (ROCE)	17.41%	7.13%	20.53%
Return on Equity Simple (ROE_SIMPLE)	16.61%	6.46%	20.10%
Net Operating Profit after Tax (NOPAT)	161	69	131
NOPAT Margin	6.36%	2.82%	5.56%
Net Nonoperating Expense Percent (NNEP)	5.77%	6.59%	-5.18%
Return On Investment Capital (ROIC_SIMPLE)	13.46%	5.69%	16.12%
Cost of Revenue to Revenue	59.10%	61.04%	64.65%
SG&A Expenses to Revenue	32.49%	33.41%	30.63%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	32.73%	35.25%	28.78%
Earnings before Interest and Taxes (EBIT)	207	90	155
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	314	185	239
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	2.87	2.47	1.77
Price to Tangible Book Value (P/TBV)	11.19	17.18	6.18
Price to Revenue (P/Rev)	0.96	0.77	0.46
Price to Earnings (P/E)	17.31	38.26	8.81
Dividend Yield	2.59%	3.17%	4.81%
Earnings Yield	5.78%	2.61%	11.35%
Enterprise Value to Invested Capital (EV/IC)	2.35	1.96	1.60
Enterprise Value to Revenue (EV/Rev)	1.08	0.94	0.54
Enterprise Value to EBITDA (EV/EBITDA)	8.71	12.38	5.31
Enterprise Value to EBIT (EV/EBIT)	13.26	25.38	8.18
Enterprise Value to NOPAT (EV/NOPAT)	17.05	33.43	9.67
Enterprise Value to Operating Cash Flow (EV/OCF)	12.08	8.57	15.64
Enterprise Value to Free Cash Flow (EV/FCFF)	16.43	0.00	0.00
Leverage & Solvency	-	-	-
Debt to Equity	0.42	0.58	0.32
Long-Term Debt to Equity	0.36	0.57	0.32
Financial Leverage	0.46	0.43	-0.24
Leverage Ratio	2.37	2.43	2.41
Compound Leverage Factor	2.06	1.74	2.28
Debt to Total Capital	29.61%	36.81%	24.28%
Short-Term Debt to Total Capital	4.21%	0.62%	0.16%
Long-Term Debt to Total Capital	25.40%	36.18%	24.12%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.03%	0.02%	0.04%
Common Equity to Total Capital	70.36%	63.17%	75.68%
Debt to EBITDA	1.12	2.40	0.83
Net Debt to EBITDA	1.03	2.21	0.75
Long-Term Debt to EBITDA	0.96	2.36	0.82
Debt to NOPAT	2.20	6.47	1.51
Net Debt to NOPAT	2.02	5.97	1.36
Long-Term Debt to NOPAT	1.89	6.36	1.50
Altman Z-Score	3.59	2.81	3.44
Noncontrolling Interest Sharing Ratio	0.04%	0.04%	0.05%
Liquidity Ratios	-	-	-
Current Ratio	1.10	1.16	1.19
Quick Ratio	0.06	0.07	0.59
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	167	-307	-539
Operating Cash Flow to CapEx	448.02%	342.51%	135.33%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	1.33	1.46	1.62
Accounts Receivable Turnover	0.00	0.00	10.44
Inventory Turnover	7.64	7.89	8.44
Fixed Asset Turnover	4.66	5.36	6.57
Accounts Payable Turnover	3.69	3.78	3.63
Days Sales Outstanding (DSO)	0.00	0.00	34.96
Days Inventory Outstanding (DIO)	47.78	46.27	43.23
Days Payable Outstanding (DPO)	99.00	96.60	100.58
Cash Conversion Cycle (CCC)	-51.22	-50.33	-22.39
Capital & Investment Metrics	-	-	-
Invested Capital	1,165	1,171	795
Invested Capital Turnover	2.16	2.48	5.14
Increase / (Decrease) in Invested Capital	-6.00	376	671
Enterprise Value (EV)	2,739	2,292	1,270
Market Capitalization	2,414	1,882	1,091
Book Value per Share	$17.57	$16.35	$14.90
Tangible Book Value per Share	$4.51	$2.35	$4.27
Total Capital	1,194	1,206	815
Total Debt	354	444	198
Total Long-Term Debt	303	436	197
Net Debt	325	409	178
Capital Expenditures (CapEx)	51	78	60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	68	45	56
Debt-free Net Working Capital (DFNWC)	97	80	75
Net Working Capital (NWC)	47	72	74
Net Nonoperating Expense (NNE)	21	19	7.45
Net Nonoperating Obligations (NNO)	325	409	178
Total Depreciation and Amortization (D&A)	108	95	84
Debt-free, Cash-free Net Working Capital to Revenue	2.71%	1.86%	2.37%
Debt-free Net Working Capital to Revenue	3.85%	3.27%	3.19%
Net Working Capital to Revenue	1.86%	2.97%	3.14%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$2.95	$1.11	$2.97
Adjusted Weighted Average Basic Shares Outstanding	47.40M	44.50M	41.70M
Adjusted Diluted Earnings per Share	$2.88	$1.09	$2.94
Adjusted Weighted Average Diluted Shares Outstanding	48.50M	45.40M	42.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	47.02M	46.89M	41.41M
Normalized Net Operating Profit after Tax (NOPAT)	165	103	94
Normalized NOPAT Margin	6.55%	4.21%	4.00%
Pre Tax Income Margin	7.10%	2.66%	6.20%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	45.59%	118.90%	42.94%
Augmented Payout Ratio	92.76%	119.51%	95.56%

This table displays calculated financial ratios and metrics derived from HNI's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/29/2025	12/28/2024	9/28/2024	6/29/2024	3/30/2024	12/30/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	10/1/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	2.01%	-5.49%	-5.54%	10.68%	22.73%	19.47%	18.84%	-9.36%	-16.29%	-5.62%	2.06%
EBITDA Growth	-11.05%	43.46%	16.75%	320.00%	111.70%	31.12%	-19.92%	-62.96%	-36.14%	32.42%	117.55%
EBIT Growth	-17.85%	77.52%	21.30%	1,583.33%	364.06%	33.48%	-30.56%	-112.00%	-68.63%	93.28%	209.85%
NOPAT Growth	-24.90%	37.36%	16.91%	1,758.39%	786.73%	68.69%	-30.32%	-107.73%	-82.79%	91.68%	215.31%
Net Income Growth	-21.47%	69.47%	25.66%	381.25%	1,006.25%	38.65%	-40.10%	-142.24%	-88.73%	99.22%	228.65%
EPS Growth	-21.62%	41.82%	22.50%	350.00%	825.00%	44.74%	-47.02%	-141.67%	-87.88%	90.00%	251.16%
Operating Cash Flow Growth	393.02%	-51.24%	4.73%	128.00%	-124.86%	121.99%	107.61%	63.04%	144.36%	9.74%	15.43%
Free Cash Flow Firm Growth	138.39%	113.95%	-37.06%	-32.75%	-813.84%	47.09%	999.26%	376.41%	-93.66%	-221.28%	-43.48%
Invested Capital Growth	-15.75%	-0.51%	-36.16%	-23.97%	132.95%	47.30%	-39.60%	-32.02%	-13.37%	540.10%	15.27%
Revenue Q/Q Growth	-6.65%	-4.42%	7.78%	6.07%	-13.50%	-4.47%	26.28%	17.62%	-15.80%	-4.98%	-3.68%
EBITDA Q/Q Growth	-39.29%	-14.55%	20.55%	42.25%	-2.09%	-30.46%	333.68%	-28.30%	-39.36%	-57.53%	100.58%
EBIT Q/Q Growth	-55.23%	-20.90%	29.03%	79.80%	-3.26%	-45.95%	1,677.78%	-156.25%	-72.17%	-71.88%	172.67%
NOPAT Q/Q Growth	-57.44%	-20.37%	26.72%	74.90%	-22.17%	-32.22%	1,897.47%	-193.52%	-85.19%	-72.00%	99.47%
Net Income Q/Q Growth	-63.71%	-19.37%	31.94%	103.39%	-21.68%	-40.21%	395.31%	-900.00%	-90.18%	-74.17%	108.25%
EPS Q/Q Growth	-62.82%	-20.41%	30.67%	102.70%	-32.73%	-31.25%	366.67%	-850.00%	-89.47%	-74.83%	109.72%
Operating Cash Flow Q/Q Growth	-75.39%	-60.16%	150.49%	1,293.02%	-104.10%	-14.43%	445.33%	30.06%	-63.42%	-19.97%	328.26%
Free Cash Flow Firm Q/Q Growth	81.33%	-78.68%	27.67%	177.80%	-153.61%	-196.18%	36.41%	725.77%	104.88%	-1,534.73%	58.07%
Invested Capital Q/Q Growth	-68.15%	281.47%	-28.78%	-2.66%	9.77%	144.77%	-15.18%	198.25%	-76.21%	0.37%	-4.53%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	39.75%	40.54%	41.48%	41.90%	39.59%	40.19%	40.09%	38.24%	36.38%	36.54%	34.99%
EBITDA Margin	8.32%	12.79%	14.31%	12.79%	9.54%	8.43%	11.58%	3.37%	5.53%	7.68%	17.18%
Operating Margin	4.07%	8.48%	10.25%	8.56%	5.05%	4.52%	7.98%	-0.64%	1.34%	4.04%	13.68%
EBIT Margin	4.07%	8.48%	10.25%	8.56%	5.05%	4.52%	7.98%	-0.64%	1.34%	4.04%	13.66%
Profit (Net Income) Margin	2.32%	5.96%	7.07%	5.77%	3.01%	3.32%	5.31%	-2.27%	0.33%	2.86%	10.54%
Tax Burden Percent	73.55%	77.37%	76.86%	78.26%	80.45%	100.00%	79.75%	142.22%	42.11%	79.13%	79.37%
Interest Burden Percent	77.46%	90.83%	89.70%	86.14%	74.07%	73.62%	83.45%	250.00%	59.38%	89.57%	97.19%
Effective Tax Rate	26.46%	22.63%	23.14%	21.74%	19.55%	0.00%	20.25%	0.00%	57.89%	20.87%	20.63%
Return on Invested Capital (ROIC)	18.71%	14.20%	51.54%	35.14%	32.83%	11.18%	23.28%	-1.42%	6.26%	16.44%	35.16%
ROIC Less NNEP Spread (ROIC-NNEP)	17.72%	13.14%	50.14%	33.97%	30.86%	8.42%	21.02%	-3.89%	5.73%	17.76%	33.60%
Return on Net Nonoperating Assets (RNNOA)	23,945.81%	6.02%	65,453.72%	56,175.06%	32,348.09%	3.59%	23.00%	-5.75%	3,744.60%	-4.23%	6.61%
Return on Equity (ROE)	23,964.52%	20.22%	65,505.25%	56,210.20%	32,380.92%	14.77%	46.28%	-7.17%	3,750.86%	12.21%	41.77%
Cash Return on Invested Capital (CROIC)	55.29%	14.27%	82.01%	55.65%	-51.47%	-31.28%	58.26%	49.24%	72.91%	-117.37%	2.39%
Operating Return on Assets (OROA)	5.48%	11.27%	13.37%	11.10%	7.80%	6.58%	10.55%	-0.77%	2.08%	6.56%	21.58%
Return on Assets (ROA)	3.12%	7.92%	9.22%	7.48%	4.65%	4.84%	7.02%	-2.74%	0.52%	4.65%	16.65%
Return on Common Equity (ROCE)	0.00%	20.21%	0.00%	0.00%	0.00%	14.77%	0.00%	0.00%	0.00%	12.20%	0.00%
Return on Equity Simple (ROE_SIMPLE)	16.89%	0.00%	14.62%	14.48%	8.46%	0.00%	5.79%	9.54%	18.16%	0.00%	19.10%
Net Operating Profit after Tax (NOPAT)	18	42	53	42	24	31	45	-2.52	2.69	18	65
NOPAT Margin	2.99%	6.56%	7.88%	6.70%	4.06%	4.52%	6.37%	-0.45%	0.56%	3.20%	10.86%
Net Nonoperating Expense Percent (NNEP)	1.00%	1.05%	1.39%	1.17%	1.97%	2.76%	2.26%	2.47%	0.54%	-1.32%	1.57%
Return On Investment Capital (ROIC_SIMPLE)	4.43%	3.53%	-	-	-	2.55%	-	-	-	2.23%	-
Cost of Revenue to Revenue	60.25%	59.47%	58.52%	58.10%	60.39%	59.83%	59.91%	61.74%	63.62%	63.44%	65.01%
SG&A Expenses to Revenue	34.61%	31.64%	31.00%	33.01%	34.54%	31.04%	31.38%	37.44%	35.04%	31.46%	29.76%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	35.68%	32.03%	31.24%	33.33%	34.56%	35.66%	32.12%	38.88%	35.04%	32.50%	21.31%
Earnings before Interest and Taxes (EBIT)	24	55	69	53	30	31	57	-3.60	6.40	23	82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	50	82	96	80	56	57	82	19	27	44	103
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	2.87	0.00	0.00	0.00	2.47	0.00	0.00	0.00	1.77	0.00
Price to Tangible Book Value (P/TBV)	0.00	11.19	0.00	0.00	0.00	17.18	0.00	0.00	0.00	6.18	0.00
Price to Revenue (P/Rev)	0.83	0.96	0.97	0.81	0.82	0.77	0.67	0.51	0.48	0.46	0.43
Price to Earnings (P/E)	15.48	17.31	20.01	18.54	31.75	38.26	36.48	16.56	9.84	8.81	8.80
Dividend Yield	2.96%	2.59%	2.47%	3.60%	2.88%	3.17%	3.81%	4.73%	4.84%	4.81%	5.11%
Earnings Yield	6.46%	5.78%	5.00%	5.39%	3.15%	2.61%	2.74%	6.04%	10.16%	11.35%	11.36%
Enterprise Value to Invested Capital (EV/IC)	6.68	2.35	9.11	5.94	5.71	1.96	4.27	3.01	6.79	1.60	1.52
Enterprise Value to Revenue (EV/Rev)	0.98	1.08	1.09	0.98	0.99	0.94	0.88	0.77	0.57	0.54	0.50
Enterprise Value to EBITDA (EV/EBITDA)	8.04	8.71	9.62	9.23	11.71	12.38	11.91	8.84	5.72	5.31	5.27
Enterprise Value to EBIT (EV/EBIT)	12.31	13.26	15.23	14.92	22.13	25.38	24.74	15.77	9.10	8.18	8.36
Enterprise Value to NOPAT (EV/NOPAT)	15.99	17.05	18.75	18.04	28.13	33.43	36.22	21.94	10.76	9.67	9.83
Enterprise Value to Operating Cash Flow (EV/OCF)	10.17	12.08	9.92	9.26	10.22	8.57	9.74	11.62	9.34	15.64	15.65
Enterprise Value to Free Cash Flow (EV/FCFF)	11.04	16.43	8.66	9.21	0.00	0.00	5.52	4.95	8.65	0.00	68.07
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1,349.00	0.42	1,151.33	1,541.33	1,576.67	0.58	1,695.33	1,994.00	693.00	0.32	0.34
Long-Term Debt to Equity	1,182.33	0.36	981.67	1,372.33	1,534.00	0.57	1,644.00	1,990.33	687.67	0.32	0.34
Financial Leverage	1,351.67	0.46	1,305.33	1,653.67	1,048.33	0.43	1.09	1.48	653.95	-0.24	0.20
Leverage Ratio	6,284.50	2.37	6,550.67	6,694.00	5,492.33	2.43	5.79	6.51	4,674.93	2.41	2.45
Compound Leverage Factor	4,867.91	2.16	5,875.63	5,766.37	4,068.40	1.79	4.84	16.28	2,775.74	2.16	2.38
Debt to Total Capital	99.93%	29.61%	99.91%	99.94%	99.94%	36.81%	99.94%	99.95%	99.86%	24.28%	25.60%
Short-Term Debt to Total Capital	12.35%	4.21%	14.72%	10.96%	2.70%	0.62%	3.03%	0.18%	0.77%	0.16%	0.15%
Long-Term Debt to Total Capital	87.58%	25.40%	85.19%	88.98%	97.23%	36.18%	96.91%	99.77%	99.09%	24.12%	25.45%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.07%	0.03%	0.09%	0.06%	0.06%	0.02%	0.06%	0.05%	0.14%	0.04%	0.04%
Common Equity to Total Capital	0.00%	70.36%	0.00%	0.00%	0.00%	63.17%	0.00%	0.00%	0.00%	75.68%	0.00%
Debt to EBITDA	1.31	1.12	1.19	1.68	2.20	2.40	2.96	3.11	0.93	0.83	0.91
Net Debt to EBITDA	1.22	1.03	1.05	1.56	2.05	2.21	2.79	2.96	0.84	0.75	0.81
Long-Term Debt to EBITDA	1.15	0.96	1.02	1.49	2.14	2.36	2.87	3.11	0.92	0.82	0.91
Debt to NOPAT	2.61	2.20	2.33	3.28	5.29	6.47	9.01	7.73	1.74	1.51	1.70
Net Debt to NOPAT	2.43	2.02	2.06	3.04	4.93	5.97	8.48	7.35	1.58	1.36	1.51
Long-Term Debt to NOPAT	2.29	1.89	1.98	2.92	5.15	6.36	8.74	7.71	1.73	1.50	1.69
Altman Z-Score	2.66	3.32	2.88	2.59	2.55	2.71	2.02	1.62	2.59	3.14	2.53
Noncontrolling Interest Sharing Ratio	100.00%	0.04%	100.00%	100.00%	100.00%	0.04%	100.00%	100.00%	100.00%	0.05%	100.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.19	1.10	1.09	1.20	1.29	1.16	1.14	1.22	1.27	1.19	1.17
Quick Ratio	0.59	0.06	0.58	0.61	0.64	0.07	0.58	0.58	0.59	0.59	0.05
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	87	48	226	177	-228	-345	359	263	32	-653	-40
Operating Cash Flow to CapEx	103.28%	544.68%	924.46%	309.04%	-40.19%	648.15%	507.02%	0.00%	0.00%	258.47%	428.26%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.35	1.33	1.30	1.30	1.54	1.46	1.32	1.21	1.56	1.62	1.58
Accounts Receivable Turnover	10.95	0.00	9.91	10.17	12.21	0.00	0.00	0.00	10.37	10.44	0.00
Inventory Turnover	7.19	7.64	6.91	6.78	7.62	7.89	6.38	6.08	7.32	8.44	7.67
Fixed Asset Turnover	4.74	4.66	4.66	4.62	5.61	5.36	5.11	4.78	6.32	6.57	6.74
Accounts Payable Turnover	4.21	3.69	3.44	3.74	4.45	3.78	3.25	3.25	3.83	3.63	3.50
Days Sales Outstanding (DSO)	33.33	0.00	36.85	35.90	29.90	0.00	0.00	0.00	35.19	34.96	0.00
Days Inventory Outstanding (DIO)	50.77	47.78	52.82	53.86	47.91	46.27	57.17	60.07	49.83	43.23	47.61
Days Payable Outstanding (DPO)	86.73	99.00	106.08	97.66	81.98	96.60	112.26	112.15	95.38	100.58	104.27
Cash Conversion Cycle (CCC)	-2.62	-51.22	-16.42	-7.90	-4.18	-50.33	-55.09	-52.08	-10.35	-22.39	-56.66
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	371	1,165	305	429	441	1,171	478	564	189	795	792
Invested Capital Turnover	6.25	2.16	6.54	5.24	8.08	2.48	3.66	3.17	11.14	5.14	3.24
Increase / (Decrease) in Invested Capital	-69	-6.00	-173	-135	251	376	-314	-266	-29	671	105
Enterprise Value (EV)	2,478	2,739	2,783	2,545	2,514	2,292	2,044	1,698	1,284	1,270	1,205
Market Capitalization	2,100	2,414	2,478	2,116	2,073	1,882	1,565	1,129	1,095	1,091	1,019
Book Value per Share	$0.00	$17.57	$0.00	$0.00	$0.00	$16.35	$0.00	$0.00	$0.00	$14.90	$0.00
Tangible Book Value per Share	($13.13)	$4.51	($13.40)	($13.50)	($13.71)	$2.35	($14.89)	($16.83)	($10.45)	$4.27	($10.93)
Total Capital	405	1,194	346	463	473	1,206	509	599	208	815	815
Total Debt	405	354	345	462	473	444	509	598	208	198	209
Total Long-Term Debt	355	303	295	412	460	436	493	597	206	197	207
Net Debt	377	325	305	429	441	409	478	569	189	178	186
Capital Expenditures (CapEx)	12	9.40	14	17	11	16	24	0.00	0.00	18	14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	108	68	58	111	100	45	55	80	77	56	58
Debt-free Net Working Capital (DFNWC)	136	97	98	145	132	80	86	109	96	75	81
Net Working Capital (NWC)	86	47	47	94	120	72	70	108	95	74	80
Net Nonoperating Expense (NNE)	4.04	3.87	5.46	5.79	6.20	8.10	7.50	10	1.09	1.90	1.90
Net Nonoperating Obligations (NNO)	371	325	305	429	440	409	478	564	189	178	186
Total Depreciation and Amortization (D&A)	26	28	27	26	26	27	26	23	20	21	21
Debt-free, Cash-free Net Working Capital to Revenue	4.26%	2.71%	2.27%	4.27%	3.92%	1.86%	2.38%	3.61%	3.41%	2.37%	2.41%
Debt-free Net Working Capital to Revenue	5.34%	3.85%	3.83%	5.55%	5.20%	3.27%	3.68%	4.95%	4.24%	3.19%	3.37%
Net Working Capital to Revenue	3.37%	1.86%	1.85%	3.61%	4.70%	2.97%	3.02%	4.90%	4.17%	3.14%	3.32%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.30	$0.81	$1.00	$0.76	$0.38	$0.56	$0.81	($0.30)	$0.04	$0.38	$1.53
Adjusted Weighted Average Basic Shares Outstanding	47M	47.40M	47.70M	47.20M	47.10M	44.50M	46.60M	43.30M	41.50M	41.70M	41.30M
Adjusted Diluted Earnings per Share	$0.29	$0.78	$0.98	$0.75	$0.37	$0.55	$0.80	($0.30)	$0.04	$0.38	$1.51
Adjusted Weighted Average Diluted Shares Outstanding	48M	48.50M	48.70M	48.20M	48.10M	45.40M	47.30M	43.30M	42.10M	42.20M	41.80M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	46.55M	47.02M	47.80M	47.14M	47.30M	46.89M	46.58M	46.55M	41.70M	41.41M	41.36M
Normalized Net Operating Profit after Tax (NOPAT)	23	44	54	43	24	43	50	3.15	4.48	18	25
Normalized NOPAT Margin	3.78%	6.86%	8.06%	6.95%	4.08%	6.39%	6.96%	0.56%	0.94%	3.20%	4.15%
Pre Tax Income Margin	3.15%	7.70%	9.19%	7.38%	3.74%	3.32%	6.66%	-1.60%	0.79%	3.62%	13.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	46.57%	45.59%	50.81%	54.34%	94.03%	118.90%	132.40%	80.79%	48.07%	42.94%	46.03%
Augmented Payout Ratio	122.92%	92.76%	71.08%	66.35%	98.47%	119.51%	132.40%	80.79%	84.01%	95.56%	137.50%

Frequently Asked Questions About HNI's Financials

When does HNI's financial year end?

According to the most recent income statement we have on file, HNI's fiscal year ends in December. Their fiscal year 2024 ended on December 28, 2024.

How has HNI's net income changed over the last 2 years?

HNI's net income appears to be on an upward trend, with a most recent value of $139.50 million in 2024, rising from $123.90 million in 2022. The previous period was $49.20 million in 2023. Check out HNI's forecast to explore projected trends and price targets.

What is HNI's operating income?

HNI's total operating income in 2024 was $206.50 million, based on the following breakdown:

Total Gross Profit: $1.03 billion
Total Operating Expenses: $826.90 million

How has HNI revenue changed over the last 2 years?

Over the last 2 years, HNI's total revenue changed from $2.36 billion in 2022 to $2.53 billion in 2024, a change of 7.0%.

How much debt does HNI have?

HNI's total liabilities were at $1.03 billion at the end of 2024, a 11.3% decrease from 2023, and a 29.7% increase since 2022.

How much cash does HNI have?

In the past 2 years, HNI's cash and equivalents has ranged from $17.40 million in 2022 to $28.90 million in 2023, and is currently $22.50 million as of their latest financial filing in 2024.

How has HNI's book value per share changed over the last 2 years?

Over the last 2 years, HNI's book value per share changed from 14.90 in 2022 to 17.57 in 2024, a change of 17.9%.

Related Companies

This page (NYSE:HNI) was last updated on 5/30/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

HNI (HNI) Financials

Frequently Asked Questions About HNI's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

HNI (HNI) Financials

Annual Income Statements for HNI

Quarterly Income Statements for HNI

Annual Cash Flow Statements for HNI

Quarterly Cash Flow Statements for HNI

Annual Balance Sheets for HNI

Quarterly Balance Sheets for HNI

Annual Metrics And Ratios for HNI

Quarterly Metrics And Ratios for HNI

Frequently Asked Questions About HNI's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools